Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections
- Conditions
- Respiratory Tract Infections
- Interventions
- Dietary Supplement: vitamin DDietary Supplement: placebo
- Registration Number
- NCT00973583
- Lead Sponsor
- Tampere University
- Brief Summary
The investigators earlier clinical study in 754 young Finnish men demonstrated a significant negative association of serum 25-OHD concentration with acute respiratory tract infections. The present study aimed to determine whether vitamin D supplementation may decrease the incidence of acute respiratory tract infections.
- Detailed Description
Subjects comprised 164 male conscripts at a military base in Finland. Half of the participants were randomly allocated to receive 400 IU vitamin D daily and half received placebo from October through March. Serum vitamin D and plasma parathyroid hormone concentrations were determined. Subjects were followed for 6 months and the primary outcome was the number of days absent from duty due to ARTI.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 164
Not provided
- Use vitamin D
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description vitamin D vitamin D - placebo placebo -
- Primary Outcome Measures
Name Time Method Number of days absent from duty due to respiratory tract infection 6 months
- Secondary Outcome Measures
Name Time Method The proportion of men remaining healthy throughout the 6-month study period 6 months The number needed to treat calculated from the proportion of men without any days absent from duty 6 months
Trial Locations
- Locations (1)
university of Tampere
🇫🇮Tampere, Finland